Suppr超能文献

天然生物聚合物作为细胞微囊化的附加工具应用于细胞治疗。

Natural Biopolymers as Additional Tools for Cell Microencapsulation Applied to Cellular Therapy.

作者信息

Cardoso Liana Monteiro da Fonseca, Barreto Tatiane, Gama Jaciara Fernanda Gomes, Alves Luiz Anastacio

机构信息

Laboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazil Avenue, 4365-Manguinhos, Rio de Janeiro 21045-900, Brazil.

出版信息

Polymers (Basel). 2022 Jun 29;14(13):2641. doi: 10.3390/polym14132641.

Abstract

One of the limitations in organ, tissue or cellular transplantations is graft rejection. To minimize or prevent this, recipients must make use of immunosuppressive drugs (IS) throughout their entire lives. However, its continuous use generally causes several side effects. Although some IS dose reductions and withdrawal strategies have been employed, many patients do not adapt to these protocols and must return to conventional IS use. Therefore, many studies have been carried out to offer treatments that may avoid IS administration in the long term. A promising strategy is cellular microencapsulation. The possibility of microencapsulating cells originates from the opportunity to use biomaterials that mimic the extracellular matrix. This matrix acts as a support for cell adhesion and the syntheses of new extracellular matrix self-components followed by cell growth and survival. Furthermore, by involving the cells in a polymeric matrix, the matrix acts as an immunoprotective barrier, protecting cells against the recipient's immune system while still allowing essential cell survival molecules to diffuse bilaterally through the polymer matrix pores. In addition, this matrix can be associated with IS, thus diminishing systemic side effects. In this context, this review will address the natural biomaterials currently in use and their importance in cell therapy.

摘要

器官、组织或细胞移植的局限性之一是移植物排斥反应。为了将其降至最低或加以预防,接受者必须终生使用免疫抑制药物(IS)。然而,持续使用这类药物通常会引发多种副作用。尽管已经采用了一些减少IS剂量和停药的策略,但许多患者并不适应这些方案,必须恢复常规的IS使用。因此,人们开展了许多研究,以提供可能长期避免使用IS的治疗方法。一种有前景的策略是细胞微囊化。细胞微囊化的可能性源于使用模仿细胞外基质的生物材料的机会。这种基质为细胞黏附以及新的细胞外基质自身成分的合成提供支持,随后促进细胞生长和存活。此外,通过将细胞包裹在聚合物基质中,该基质起到免疫保护屏障的作用,保护细胞免受接受者免疫系统的攻击,同时仍允许必需的细胞存活分子通过聚合物基质的孔隙双向扩散。此外,这种基质可以与IS联合使用,从而减少全身副作用。在此背景下,本综述将探讨目前正在使用的天然生物材料及其在细胞治疗中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e62c/9268758/5c17edeecb44/polymers-14-02641-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验